Loading clinical trials...
Loading clinical trials...
The investigators will test the validity of biomarkers for the detection of heavy alcohol use in patients with and without liver disease.
The investigators will test the validity of biomarkers for the detection of heavy alcohol use in patients with and without liver disease. The investigators will test the validity of carbohydrate deficient transferrin (CDT)(using capillary zone electrophoresis) in blood and ethyl glucuronide (EtG)(using Liquid Chromatography-MS-MS) in hair in patients with heavy alcohol use, moderate alcohol use and patients who do not drink alcohol.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
Yes
UZ Leuven
Leuven, Vlaams Brabant, Belgium
Start Date
December 1, 2010
Primary Completion Date
August 1, 2025
Completion Date
August 1, 2025
Last Updated
July 10, 2024
140
ESTIMATED participants
Plasma and head hair collection
PROCEDURE
Lead Sponsor
Universitaire Ziekenhuizen KU Leuven
NCT07480057
NCT07237750
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06181409